Search results
Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market - ET...
The Economic Times· 12 hours agoLondon: Democratic U.S. Senate aides will meet with Novo Nordisk executives on Tuesday to discuss fallout from its decision to stop selling one of its long-acting ...
Novo Nordisk, Indonesia's Bio Farma set to make insulin - ET HealthWorld | Pharma
The Economic Times· 3 days agoJakarta: Danish drugmaker Novo Nordisk has signed a deal with Indonesia's state-owned pharmaceutical...
Novo Nordisk shares down after analysis finds Lilly drug leads to better weight loss - ET...
The Economic Times· 4 days agoLondon: Shares in Novo Nordisk , maker of the wildly popular obesity drug Wegovy, were down 1.1 per...
US Senator Sanders optimistic Novo Nordisk can be pressured to cut Wegovy, Ozempic prices - ET...
The Economic Times· 3 days agoWashington: Senator Bernie Sanders on Wednesday expressed confidence that Novo Nordisk can be...
Novo Nordisk applies for more reimbursements for Wegovy in Norway - ET HealthWorld | Pharma
The Economic Times· 2 days agoCopenhagen: Danish drugmaker Novo Nordisk said on Thursday it had applied to the Norwegian health...
After AdCom rejection, FDA rebuffs Novo Nordisk’s once-weekly insulin
Pharmaceutical Technology· 2 days agoThe US Food and Drug Administration (FDA) has rejected the biologics licence application (BLA) for ...
Ozempic linked with lower dementia risk, nicotine use, British study finds - ET HealthWorld | Pharma
The Economic Times· 21 hours agoLondon: Novo Nordisk's popular diabetes treatment Ozempic could be tied to a lower risk of cognitive...
UK pharma group reprimands Novo Nordisk for undisclosed payments
Pharmaceutical Technology· 5 days agoThe Association of the British Pharmaceutical Industry (ABPI) has pulled up four pharmaceutical...
Pfizer along witth Eli Lilly and Novo Nordisk, enroute to develop their second generation weight...
CNBC TV18· 2 days agoPfizer plans to move a reworked, once-a-day version of its weight loss pill, danuglipron, into...
Novo’s once-weekly insulin rejected by FDA
BioPharma Dive· 2 days agoThe FDA’s decision to turn back the drugmaker’s new insulin product narrows Novo’s lead in the U.S. over Eli Lilly, which has a similar diabetes...